Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Amare AT, Schubert KO, Baune BT.

EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. Review.

2.

Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients.

Pompili M, Gentile G, Scassellati C, Bonvicini C, Innamorati M, Erbuto D, Montebovi F, Ducci G, Forte A, De Pisa E, Ferracuti S, Serafini G, De Luca V, Amore M, Simmaco M, Girardi P.

Neurosci Lett. 2017 Aug 24;656:94-102. doi: 10.1016/j.neulet.2017.07.020. Epub 2017 Jul 14.

PMID:
28716530
3.

GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population.

Ma J, Wang L, Yang Y, Qiao Z, Fang D, Qiu X, Yang X, Zhu X, He J, Pan H, Ban B, Zhao Y, Sui H.

PLoS One. 2017 Feb 22;12(2):e0170994. doi: 10.1371/journal.pone.0170994. eCollection 2017.

4.

Genetic Analysis of BDNF, GNB3, MTHFR, ACE and APOE Variants in Major and Recurrent Depressive Disorders in Russia.

Bondarenko EA, Shadrina MI, Grishkina MN, Druzhkova TA, Akzhigitov RG, Gulyaeva NV, Guekht AB, Slominsky PA.

Int J Med Sci. 2016 Dec 8;13(12):977-983. eCollection 2016.

5.

Pharmacogenetic studies: a tool to improve antidepressant therapy.

Ramos M, Berrogain C, Concha J, Lomba L, García CB, Ribate MP.

Drug Metab Pers Ther. 2016 Dec 1;31(4):197-204. doi: 10.1515/dmpt-2016-0019. Review.

PMID:
27889704
6.

Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Lett TA, Walter H, Brandl EJ.

CNS Drugs. 2016 Dec;30(12):1169-1189. Review.

PMID:
27752945
7.

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.

Su YA, Li JT, Dai WJ, Liao XM, Dong LC, Lu TL, Bousman C, Si TM.

Int Clin Psychopharmacol. 2016 May;31(3):127-33. doi: 10.1097/YIC.0000000000000115.

PMID:
26745768
8.

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.

Fabbri C, Serretti A.

Curr Psychiatry Rep. 2015 Jul;17(7):50. doi: 10.1007/s11920-015-0594-9. Review.

PMID:
25980509
9.

Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.

Gonzalez BD, Jim HS, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, Jacobsen PB.

J Clin Oncol. 2015 Jun 20;33(18):2021-7. doi: 10.1200/JCO.2014.60.1963. Epub 2015 May 11.

10.

Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis.

Hu Q, Zhang SY, Liu F, Zhang XJ, Cui GC, Yu EQ, Xu XF, Li P, Xiao JQ, Wei DM, Zang YY.

J Affect Disord. 2015 Feb 1;172:103-9. doi: 10.1016/j.jad.2014.09.039. Epub 2014 Oct 2. Review.

PMID:
25451402
11.

G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees.

Bousman CA, Potiriadis M, Everall IP, Gunn JM.

J Affect Disord. 2014 Aug;165:64-8. doi: 10.1016/j.jad.2014.04.044. Epub 2014 Apr 24.

PMID:
24882179
12.

Pharmacogenetics in major depression: a comprehensive meta-analysis.

Niitsu T, Fabbri C, Bentini F, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:183-94. doi: 10.1016/j.pnpbp.2013.05.011. Epub 2013 Jun 1. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:118-9.

PMID:
23733030
13.

European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.

Schosser A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2012 Jul;22(7):453-68. doi: 10.1016/j.euroneuro.2012.02.006. Epub 2012 Mar 30. Review.

PMID:
22464339
14.

Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.

Serretti A, Chiesa A, Crisafulli C, Massat I, Linotte S, Calati R, Kasper S, Bailer U, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J.

Neuropsychobiology. 2012;65(2):70-5. doi: 10.1159/000329553. Epub 2012 Jan 5.

PMID:
22222462
15.

The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression.

Klenke S, Kussmann M, Siffert W.

Pharmacogenet Genomics. 2011 Sep;21(9):594-606. doi: 10.1097/FPC.0b013e3283491153. Review.

PMID:
21709600
16.

Variation in GNB3 predicts response and adverse reactions to antidepressants.

Keers R, Bonvicini C, Scassellati C, Uher R, Placentino A, Giovannini C, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Hauser J, Souery D, Mendlewicz J, Schmäl C, Zobel A, Larsen ER, Szczepankiewicz A, Kovacic Z, Elkin A, Craig I, McGuffin P, Farmer AE, Aitchison KJ, Gennarelli M.

J Psychopharmacol. 2011 Jul;25(7):867-74. doi: 10.1177/0269881110376683. Epub 2010 Sep 8.

PMID:
20826553
17.

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.

Lin E, Chen PS, Chang HH, Gean PW, Tsai HC, Yang YK, Lu RB.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1167-72. doi: 10.1016/j.pnpbp.2009.06.015. Epub 2009 Jun 26.

PMID:
19560507
18.

Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

Kato M, Wakeno M, Okugawa G, Fukuda T, Takekita Y, Hosoi Y, Azuma J, Kinoshita T, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1041-4. doi: 10.1016/j.pnpbp.2008.01.019. Epub 2008 Feb 13.

PMID:
18325652
19.

Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression.

Kang RH, Hahn SW, Choi MJ, Lee MS.

Neuropsychobiology. 2007;56(1):1-5. Epub 2007 Oct 17.

PMID:
17943025
20.

Meta-analyses of genetic studies on major depressive disorder.

López-León S, Janssens AC, González-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, van Duijn CM.

Mol Psychiatry. 2008 Aug;13(8):772-85. Epub 2007 Oct 16.

PMID:
17938638

Supplemental Content

Loading ...
Support Center